Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate versus propofol for induction in cardiac surgery under general anesthesia
ChiCTR2200055632Phase 4Recruiting
- Sponsor
- Fuwai Central China Cardiovascular Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial comparing Propofol induction with Remimazolam besylate induction (2 arms). Primary endpoint: Changes in sublingual microcirculation. Started Jan 2022; status: recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2200055632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055632.